These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26161196)

  • 1. [Risk factors for treatment adherence in patients with schizophrenia: case-control study].
    Aarab C; Elghazouani F; Aalouane R; Rammouz I
    Pan Afr Med J; 2015; 20():273. PubMed ID: 26161196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplifying adherence in schizophrenia.
    Hardeman SM; Harding RK; Narasimhan M
    Psychiatr Serv; 2010 Apr; 61(4):405-8. PubMed ID: 20360281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of barriers to medication adherence in schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
    J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Compliance].
    Vandel P
    Encephale; 2007 Jun; 33 Pt 3():S399-401. PubMed ID: 19101359
    [No Abstract]   [Full Text] [Related]  

  • 7. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drowning in numbers-what psychiatrists mean when talking to patients about probabilities of risks and benefits of medication.
    Hamann J; Mendel R; Bühner M; Leucht S; Kissling W
    Eur Psychiatry; 2011 Mar; 26(2):130-1. PubMed ID: 21067902
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse.
    Voruganti LN; Heslegrave RJ; Awad AG
    J Nerv Ment Dis; 1997 Jul; 185(7):463-5. PubMed ID: 9240366
    [No Abstract]   [Full Text] [Related]  

  • 10. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
    Ameller A; Gorwood P
    Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adherence to neuroleptic treatment of schizophrenic patients].
    Blondiaux I; Alagille M; Ginestet D
    Encephale; 1988; 14(6):431-8. PubMed ID: 2906607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of relapse in the year after hospital discharge among patients with schizophrenia.
    Schennach R; Obermeier M; Meyer S; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    Psychiatr Serv; 2012 Jan; 63(1):87-90. PubMed ID: 22227766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportion and reasons for medication non-compliance among schizophrenics: A cross-sectional observation in a tertiary care hospital of Bangladesh.
    Arafat SMY; Mali B; Akter H
    Asian J Psychiatr; 2018 Jun; 35():52-54. PubMed ID: 29783135
    [No Abstract]   [Full Text] [Related]  

  • 14. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
    Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.
    Valenstein M; Ganoczy D; McCarthy JF; Myra Kim H; Lee TA; Blow FC
    J Clin Psychiatry; 2006 Oct; 67(10):1542-50. PubMed ID: 17107245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
    Jaeger S; Weißhaupt S; Flammer E; Steinert T
    Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
    Vassileva I; Milanova V; Asan T
    Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
    El Ammouri A; Kisra H
    Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NIMH-CATIE Schizophrenia Study: what did we learn?
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2011 Aug; 168(8):770-5. PubMed ID: 21813492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.